Call to a nurse practitioner about a new antibiotic
PEBC OSCE practice station
Telephone consultation · 2 min to read · 7 min to perform
A new prescription for Mr Alan Brodeur, aged 66, has arrived from a nurse practitioner: clarithromycin 500 mg twice daily for seven days for a chest infection.
Free · no sign-up · uses your one free station
Open the full station (charts, voice, result letter) →The task
You are a pharmacist in a community pharmacy. A new prescription for Mr Alan Brodeur, aged 66, has arrived from a nurse practitioner: clarithromycin 500 mg twice daily for seven days for a chest infection. Mr Brodeur has already left. His profile is in the patient folder. You have reviewed it and decided to call the prescriber, nurse practitioner Sophie Gagnon, who has just picked up. State the problem and your recommendation, answer her questions and agree on an outcome. The assessor will not take part in the conversation.
Studying with someone? Practise this station with a friend, free →
Answer for this station
What a strong answer does
- Introduces self and the patient clearly, and states the problem concisely: clarithromycin with simvastatin 40 mg.
- Safety: Explains the mechanism and risk: clarithromycin strongly inhibits CYP3A4, raising simvastatin levels and the risk of myopathy and rhabdomyolysis; the combination is contraindicated.
- Asks about the diagnosis, severity and allergies to guide a suitable alternative.
- Recommends a specific alternative that avoids the interaction, with drug, dose and duration, such as doxycycline 100 mg twice daily for 5 days, with or without amoxicillin-clavulanate because of his coronary disease, justifies the choice and leaves the final decision with the prescriber.
- States what to do about the simvastatin if clarithromycin is still preferred: hold simvastatin for the course and reassess.
- Agrees a clear plan: new prescription, who contacts the patient, counselling on the antibiotic and on continuing his statin.
- Maintains a collegial, non-accusatory tone and acknowledges her time pressure.
- Proposes follow-up and documents the intervention and the outcome.
- Closes the loop by confirming the plan and the specifics back to the prescriber.
Model answer
I introduce myself to the nurse practitioner and identify the patient by name and date of birth. I state the problem straight away: the new clarithromycin conflicts with his simvastatin 40 mg taken nightly, and I explain that the prescription was written without that information. I explain the mechanism. Clarithromycin is a strong inhibitor of CYP3A4, the enzyme that clears simvastatin, so simvastatin levels rise and the risk of muscle injury, including rhabdomyolysis, increases. The combination is listed as a contraindication in the Canadian monograph. I ask about the diagnosis and learn it is mild community-acquired pneumonia with stable vital signs and no allergy. I recommend doxycycline 100 mg twice daily for 5 days, which avoids the interaction. Because of his coronary disease she may want broader cover by adding amoxicillin-clavulanate. If she wants to stay with a macrolide, azithromycin has little effect on simvastatin. I leave the final choice to her. I add that if she prefers clarithromycin, simvastatin would need to be held during the course and he must be told about muscle symptoms. I note that he has a coronary stent, so I do not want his statin stopped without good reason. We agree on the new prescription. I offer to call Mr Brodeur, tell him to wait for the replacement, and counsel him on the new antibiotic and on continuing his statin. I confirm the plan back to her, thank her for her time, document the intervention and the outcome in his profile, and suggest a follow-up check in a few days.
What this station tests
- State the drug, dose and mechanism of harm in the first sentences of a prescriber call.
- Offer a specific alternative so the prescriber can say yes on the call.
- Keep the tone collegial; the prescriber often lacks the full list.
- Also address what happens to the other drug and who tells the patient.
- Document the intervention.
Sources for the clinical content
- Zocor (simvastatin) Canadian product monograph
- ATS/IDSA 2019 guideline: adults with community-acquired pneumonia
- NAPRA: Model Standards of Practice for Pharmacists and Pharmacy Technicians in Canada
An original practice scenario with invented patients. Not an exam question. Written from the guidance above and reviewed before release: how we write and check stations.